General Information of Drug (ID: DM3FKLV)

Drug Name
AZD-4121
Synonyms Lipid metabolism therapeutic, AstraZeneca
Indication
Disease Entry ICD 11 Status REF
Lipid metabolism disorder 5C52.Z Discontinued in Phase 1 [1]
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C36H39F2N3O7S
Canonical SMILES
C1CCC(CC1)CC(C(=O)O)NC(=O)CNC(=O)COC2=CC=C(C=C2)C3C(C(=O)N3C4=CC=C(C=C4)F)SCC(C5=CC=C(C=C5)F)O
InChI
1S/C36H39F2N3O7S/c37-25-10-6-23(7-11-25)30(42)21-49-34-33(41(35(34)45)27-14-12-26(38)13-15-27)24-8-16-28(17-9-24)48-20-32(44)39-19-31(43)40-29(36(46)47)18-22-4-2-1-3-5-22/h6-17,22,29-30,33-34,42H,1-5,18-21H2,(H,39,44)(H,40,43)(H,46,47)/t29-,30+,33-,34-/m1/s1
InChIKey
FNTLQLXIDNNELB-GBWWDHKLSA-N
Cross-matching ID
PubChem CID
67273740
CAS Number
1369489-34-8
TTD ID
D0YP6F

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026709)